Freve Jonathan 4
4 · Spring Bank Pharmaceuticals, Inc. · Filed Jan 17, 2018
Insider Transaction Report
Form 4
Freve Jonathan
CFO, Treasurer & Secretary
Transactions
- Award
Stock Option (Right to Buy)
2018-01-16+27,000→ 27,000 totalExercise: $12.10Exp: 2028-01-16→ Common Stock (27,000 underlying)
Footnotes (1)
- [F1]This option was granted on January 16, 2018, with 25% of the shares subject to the option vesting on January 16, 2019 and the remaining 75% of the shares subject to the option vesting in 36 equal monthly installments thereafter.